HCW Biologics's market cap is currently $17.42M. The company's EPS TTM is $-1.004; its P/E ratio is ―; HCW Biologics is scheduled to report earnings on April 1, 2025, and the estimated EPS forecast is $0.09. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 2.84M	$ 6.72M	$ 0.00	$ 4.10M	$ 0.00
Gross Profit	$ 560.36K	$ 2.59M	$ -543.60K	$ 4.10M	$ -421.82K
Operating Income	$ -25.72M	$ -15.08M	$ -13.37M	$ -5.82M	$ -7.37M
EBITDA	$ -23.58M	$ -14.18M	$ -12.82M	$ -5.25M	$ -6.94M
Net Income	$ -24.99M	$ -14.72M	$ -12.36M	$ -5.78M	$ -7.22M
Balance Sheet
Cash & Short-Term Investments	$ 3.60M	$ 32.06M	$ 36.71M	$ 8.46M	$ 7.36M
Total Assets	$ 28.51M	$ 46.81M	$ 53.51M	$ 15.40M	$ 10.07M
Total Debt	$ 6.30M	$ 6.41M	$ 0.00	$ 567.31K	$ 0.00
Net Debt	$ 2.71M	$ -15.92M	$ -11.73M	$ -7.89M	$ -7.36M
Total Liabilities	$ 15.05M	$ 9.38M	$ 2.32M	$ 1.00M	$ 1.07M
Stockholders' Equity	$ 13.46M	$ 37.43M	$ 51.19M	$ 14.40M	$ 9.00M
Cash Flow
Free Cash Flow	$ -28.72M	$ -20.66M	$ -11.02M	$ -10.62M	$ -8.23M
Operating Cash Flow	$ -22.51M	$ -10.39M	$ -10.98M	$ -10.43M	$ -6.77M
Investing Cash Flow	$ 3.80M	$ 14.71M	$ -35.02M	$ -186.68K	$ -1.46M
Financing Cash Flow	$ -14.53K	$ 6.27M	$ 49.27M	$ 11.72M	$ 13.45M

Currency in USD

HCW Biologics Earnings and Revenue History

Income Statement >

HCW Biologics Debt to Assets

Balance Sheet >

HCW Biologics Cash Flow

Cash Flow >

HCW Biologics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing